AA	acceptor splice site
AD	alternative donor
AP	alternative promotor
AS	alternative splicing
AT	alternative terminator
AUC	area under the curve
BH	Benjamin–Hochberg
DCA	decision curve analysis
DFS	disease-free survival
ER	estrogen receptor
ES	acceptor splice site
FDR	false discovery rate
HR	hazard ratio
IR	intron retention
KM	Kaplan–Meier
LASSO	Least Absolute Shrinkage Selection Operator
ME	mutual exclusive exon usage
OS	overall survival
PSI	Percent Spliced In
RI	retained intron
ROC	receiver operating characteristic
TCGA	The Cancer Genome Atlas